Estimating Respiratory Modulation in Atrial Fibrillation Using a Convolutional Neural Network

Felix Plappert1, mikael wallman2, Pyotr Platonov1, Frida Sandberg1
1Lund University, 2fraunhofer-chalmers centre


Abstract

Aims: The autonomic nervous system (ANS) can initialize and maintain but also terminate atrial fibrillation (AF). Currently, there is a lack of methods to estimate ANS activity from ECG data of subjects in AF. In the present study, we investigate the feasibility of estimating ANS-induced respiratory modulation in AV nodal conduction properties in a simulation study. Methods: A convolutional neural network (CNN) is trained on simulated data, corresponding to what can be acquired from 1-min ECG segments. Simulated RR series are generated using an AV node network model with refractory period (R) and conduction delay (D) dependent on the stimulation history and respiratory modulation defined by the amplitude aresp and frequency fresp. The respiration signals are extracted from sinusoidal signals with the frequency fresp and added noise to mimic ECG-derived respiration signals, using the periodic component analysis (πCA). The AFR is used both as input to the CNN and as model parameter to generate the atrial impulse series entering the AV node. The CNN is trained to predict aresp using simulated data from 100000 unique model parameter sets, with aresp ranging from 0-0.2, where aresp=0.2 corresponds to an increase and decrease of R and D by up to 20%. Results: An example of simulated RR series and respiration signal resembling a clinical data is displayed in Fig.1. The respiration signal extraction based on πCA can both extract the respiration signal and estimate the respiration frequency without prior knowledge under the assumption that the respiratory modulation is the most periodic component in the EDR signals. The CNN can estimate aresp with an RMSE of 0.0274 in simulated data. Conclusion: Our simulation results suggest respiratory modulation in AV node conduction can be estimated from ECG data, which may be valuable in personalized AF treatment. Further studies are needed to validate the estimates.